Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?

Coghlan Gerry

Source: Eur Respir J 2013; 42: 888-890
Journal Issue: October
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Coghlan Gerry. Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?. Eur Respir J 2013; 42: 888-890

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Under pressure: pulmonary hypertension associated with left heart disease
Source: Eur Respir Rev 2015; 24: 665-673
Year: 2015



Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018



TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form
Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020
Year: 2020



Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012


Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019



How to define pulmonary hypertension due to left heart disease
Source: Eur Respir J 2016; 48: 553-555
Year: 2016


Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011



Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension?
Source: Eur Respir J 2007; 30: 928-936
Year: 2007



Predictors of pulmonary artery hypertension in patients with systemic sclerosis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012


Pulmonary hypertension in left heart, respiratory and trombo-embolic pulmonary disease
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015



Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004

Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018
Year: 2018



Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017
Year: 2018



Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 50 (5) 1701436; 10.1183/13993003.01436-2017
Year: 2017



Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005


Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006